ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod; RHO data show efgartigimod achieved susta ...

The diabetic nephropathy market is driven by the growing burden of diabetes and the increasing demand for effective treatments for kidney disease. Advances in therapeutics, including new drug classes ...